 |
|
|
| |
In Vivo Pharmacodynamics of GS-5801, a Liver-Targeted Prodrug of a Lysine
Demethylase-5 Inhibitor With Antiviral Activity Against Hepatitis B Virus
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Sarah A. Gilmore, Chelsea A. Snyder, Ryan Dick, Mike Matles, Danny Tam, Chin H. Tay, Julie Farand, Eric Paoli, William E. Delaney IV, Becket Feierbach, Gregory T. Notte
Gilead Sciences, Inc., Foster City, California, USA
References
1. Secombe J, Eisenman RN. Cell Cycle 2007;6:1324-8; 2. Torres IO, et al. Nat Commun 2015;6:6204; 3. Johansson C, et al. Nat Chem Biol 2016;12:539-45; 4. Kidder BL, et al. Genome Biol 2014;15:R32; 5. Santos-Rosa H, et al. Nature 2002;419:407-11; 6. Sims RJ 3rd, et al. Trends Genet 2003;19:629-39.
|
| |
|
|
|
|
|
